Disease progression parameters and uses thereof for evaluating multiple sclerosis
Patent Information
- Authority / Receiving Office
- US ยท United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- BIOGEN MA INC
- Publication Date
- 2015-08-06
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional Application No. 61 / 682,521, filed Aug. 13, 2012, the contents of which are incorporated herein by reference in their entirety.BACKGROUND OF THE INVENTION
[0002] Multiple sclerosis (MS) is an inflammatory disease of the brain and spinal cord characterized by recurrent foci of inflammation that lead to destruction of the myelin sheath. In many areas, nerve fibers are also damaged. Inflammatory activity in MS patients tends to be highest in the initial phase of disease.
[0003] Emerging data demonstrate that irreversible axonal loss occurs early in the course of MS. Transected axons fail to regenerate in the central nervous system (CNS) and therefore, early treatment aimed at suppressing MS lesion formation is of paramount importance. As early as disease onset, axons are transected in lesions with active inflammation (Trapp et al. (1998) N Engl J Med 338: 278-285; Bjartmar et al. (2001) Curr Opin Neurol 14: 27...